Stock screenerAll disclosures →
EDGAR →
CVS
Conviction 45HealthcareScan · Thu, Sep 24, 2026CVS HEALTH Corp (CVS) closed at $85.06 (-0.94%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 23, RS Rating 47, -23.1% from its 52-week high, +6.2% year to date. Sector: Healthcare · RETAIL-DRUG STORES AND PROPRIETARY STORES.
CVS$85.06-0.94%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 7.75M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +0.00%· 1 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price85.06
Change-0.94%
Gap-0.07%
Rel volume1.91×
Avg volume7.32M
Avg $ vol669.75M
SMA 2092.83
SMA 5097.42
SMA 20087.45
Price vs 50-12.69%
Price vs 200-2.73%
MA stackmixed
50/200 cross—
Supertrenddown · 91.43
RSI (14)23
MACD hist-0.84
MACD crossbear · 5d
Stoch %K / %D4 / 3
ADX (14)39
+DI / −DI8 / 41
RSI divergenceBullish
MACD divergenceBullish
ATR %2.52%
ADR %2.16%
52w high110.60
52w low70.08
From 52w high-23.10%
Above 52w low+21.37%
New 52w highNo
SqueezeOff
Bollinger width16.89%
%B0.00
Donchian pos3.96%
Donchian high98.50
Donchian low84.50
AVWAP (52w high)96.07
vs AVWAP high-11.46%
AVWAP (52w low)93.51
vs AVWAP low-9.04%
OBV trendDown
Chaikin MF (20)-0.30
Today vs 20d1.91×
Avg vol (14d)7.75M
Avg vol (20d)7.32M
Avg $ vol (20d)669.75M
Market cap108.78B
RS Rating47 / 99
RS 3m (vs SPY)-23.22%
RS 6m (vs SPY)+1.02%
RS line new highNo
Trend template4/8
Technical rank43.2
1 week-5.78%
1 month-8.44%
3 months-18.73%
6 months+17.84%
1 year+11.18%
YTD+6.15%
P/E61.53
P/B1.36
P/S0.56
P/FCF13.93
EPS1.39
Div yield3.12%
ROE2.22%
ROA0.70%
Debt/Eq0.90
Current0.87
EV/EBITDA18.25
Gross margin14.72%
Net margin0.91%
Rev growth4.95%
EPS growth-61.68%
Price target114.37
Target upside34.47%
Analyst ratingBuy
Institutional99.54%
Ent. value169.13B
Revenue64.55B
Net income2.98B
Gross profit7.33B
Free cash flow7.81B
IndustryRETAIL-DRUG STORES AND PROPRIETARY STORES
ExchangeNYSE
Shares out1.28B
Employees300K
ListedWed, Oct 1, 1952
Free float1.26B
Float %99.3%
Short interest18.11M
Days to cover2.8d
Short volume26.5%
Squeeze score31 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.58 vs $1.87
Last surprise+38.0% beat
Setup gradeC
Conviction45 / 100
Pattern quality—
Tech rank43.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance98.00
Support92.66
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- As measles cases rise in Tennessee, CVS Health® reminds residents that vaccines are available statewidePR Newswire · Wed, Sep 23, 2026
Congress activity
Disclosed STOCK Act trades in CVS · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H Tuberville senate · traded 2024-08-26 | Sell | $1K–$15K | 2024-08-26 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 John Boozman senate · R · AR · traded 2026-01-29 | Buy | $1K–$15K | 2026-01-29 | 2026-02-15 | |
 Dwight Evans house · PA · traded 2025-11-21 | Sell | $1K–$15K | 2025-11-21 | 2025-12-05 | |
 Lisa McClain house · MI · traded 2025-10-31 | Sell | $1K–$15K | 2025-10-31 | 2025-11-01 | |
Lisa McClain house · MI · traded 2025-10-30 | Buy | $1K–$15K | 2025-10-30 | 2025-11-01 | |
 Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
 Adam Smith house · D · WA · traded 2025-08-08 | Sell | $1K–$15K | 2025-08-08 | 2025-08-08 | |
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 |
Insider activity
SEC Form 4 transactions in CVS · open-market 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Clark James David SVP, Cont & Chief Acct Officer · Common Stock (Restricted) · 2026-06-26 | Tax | 454 | $41K | 2026-06-26 | 2026-06-29 |
Newman Brian EVP, Chief Financial Officer · Common Stock · 2026-05-31 | Tax | 2.48K | $225K | 2026-05-31 | 2026-06-01 |
Compton-Phillips Amy EVP, Chief Medical Officer · Common Stock · 2026-05-31 | Tax | 7.62K | $693K | 2026-05-31 | 2026-06-01 |
AGUIRRE FERNANDO Director · Common Stock · 2026-05-21 | Disposition | 1.56K | $146K | 2026-05-21 | 2026-05-22 |
AGUIRRE FERNANDO Director · Common Stock · 2026-05-20 | Disposition | 30.44K | $2.9M | 2026-05-20 | 2026-05-22 |
ROBBINS LARRY Director · Cash-Settled Swaps · 2026-05-21 | Sell | 378K | $35M | 2026-05-21 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-21 | Sell | 370.46K | $35M | 2026-05-21 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 797.63K | $75M | 2026-05-20 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 800 | $77K | 2026-05-20 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 66.88K | $6.4M | 2026-05-20 | 2026-05-21 |
SEC filings
EDGAR filings in CVS · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.